These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34237731)

  • 1. Role of Autoantibodies in Neurodegenerative Dementia: An Emerging Association.
    Arshad F; Varghese F; Paplikar A; Gangadhar Y; Ramakrishnan S; Chaudhuri JR; Mahadevan A; Alladi S
    Dement Geriatr Cogn Disord; 2021; 50(2):153-160. PubMed ID: 34237731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.
    Longobardi A; Catania M; Geviti A; Salvi E; Vecchi ER; Bellini S; Saraceno C; Nicsanu R; Squitti R; Binetti G; Di Fede G; Ghidoni R
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of QOL between patients with different degenerative dementias, focusing especially on positive and negative affect.
    Kurisu K; Terada S; Oshima E; Horiuchi M; Imai N; Yabe M; Yokota O; Ishihara T; Yamada N
    Int Psychogeriatr; 2016 Aug; 28(8):1355-61. PubMed ID: 27020694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
    Chaudhry A; Houlden H; Rizig M
    J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
    Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
    J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.
    Beagle AJ; Darwish SM; Ranasinghe KG; La AL; Karageorgiou E; Vossel KA
    J Alzheimers Dis; 2017; 60(1):211-223. PubMed ID: 28826176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies.
    Binnewijzend MA; Kuijer JP; van der Flier WM; Benedictus MR; Möller CM; Pijnenburg YA; Lemstra AW; Prins ND; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Eur Radiol; 2014 Sep; 24(9):2326-33. PubMed ID: 24996793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative transcranial magnetic stimulation study: Assessing cortical excitability and plasticity in Alzheimer's disease, dementia with Lewy bodies and Frontotemporal dementia.
    Olğun Y; Aksoy Poyraz C; Bozluolçay M; Gündüz A; Poyraz BÇ
    Psychogeriatrics; 2024 Mar; 24(2):272-280. PubMed ID: 38131520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Biomarkers in Neurodegenerative Dementias: Unrevealing the Potential of Serum Oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and Prolactin.
    Olğun Y; Poyraz CA; Bozluolçay M; Konukoğlu D; Poyraz BÇ
    Curr Alzheimer Res; 2024; 21(2):109-119. PubMed ID: 38803182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer's disease: clinical experience in China.
    Liu S; Jin Y; Shi Z; Huo YR; Guan Y; Liu M; Liu S; Ji Y
    Aging Ment Health; 2017 Jun; 21(6):651-657. PubMed ID: 26882509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.
    Herbert MK; Aerts MB; Kuiperij HB; Claassen JAHR; Spies PE; Esselink RAJ; Bloem BR; Verbeek MM
    Alzheimers Dement; 2014 Jul; 10(4):448-455.e2. PubMed ID: 24239248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can clock drawing differentiate Alzheimer's disease from other dementias?
    Tan LP; Herrmann N; Mainland BJ; Shulman K
    Int Psychogeriatr; 2015 Oct; 27(10):1649-60. PubMed ID: 26138809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
    Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
    Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
    Cressot C; Vrillon A; Lilamand M; Francisque H; Méauzoone A; Hourregue C; Dumurgier J; Marlinge E; Paquet C; Cognat E
    J Alzheimers Dis; 2024; 99(1):85-99. PubMed ID: 38669539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
    Arnaldi D; Donniaquio A; Mattioli P; Massa F; Grazzini M; Meli R; Filippi L; Grisanti S; Famà F; Terzaghi M; Girtler N; Brugnolo A; Doglione E; Pardini M; Villani F; Nobili F
    J Alzheimers Dis; 2020; 74(3):865-874. PubMed ID: 32116260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease.
    Piguet O; Halliday GM; Creasey H; Broe GA; Kril JJ
    Int Psychogeriatr; 2009 Aug; 21(4):688-95. PubMed ID: 19493380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.